Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality

UZ Gent, Ghent

UZ Gasthuisberg, Leuven

CHU Mont Godine, Yvoir

AZ St-Jan Brugge AV, Bruges

Korolinska Institutet Department of Hematology, Stockholm

Ospedale Niguarda Ca Granda, Milan

University of Pavia Division of Hematology, Pavia

CHU Purpan, Place du Dr Baylac, Pavillon des Médecines, Toulouse

CHU Purpan, Place du Dr. Baylac, Pavillion des Medecines, Toulouse

Hospital Universitario de Salamanca, Salamanca

CHU Nantes Hematologie et Medicine interne, Nantes

Hospital Universitario La Fe, Valencia

St Johannes Hospital, Duisburg

CHU d'Angers Service des Maladies du Sang, Angers

CHU Nancy Hematologie et Medecine interne, Vandœuvre-lès-Nancy

CHRU Lille Service des Maladies du Sang, Lille

Tel Aviv Sourasky Medical Center, Tel Aviv

Hôpital Cochin Hematologie Clinique, Paris

Centre Henri Becquerel Service d'Hematologie Clinique, Rouen

Universitaetsklinikum Freiburg, Freiburg im Breisgau

Centre Jean Bernhard Service Onco-Hematologie, Poitiers

Institut Paoli-Calmettes, Marseille

Hopital Avicenne, Bobigny

CHU Archet 1Hematologie Clinique, Nice

Universitaetsklinikum Carl Gustav Carus, Dresden

Hannover Medical School, Hanover

University of Medical Centre, Nijmegen

Hematologie Erasmus MC, Rotterdam

SU/Sahlgrenska Section of Hematology & Coagulation, Gothenburg

Department of Medicine University Hospital, Lund

University Hospital of Wales, Dept of Haematology, Cardiff

Leed General Infirmary, Leeds

The Royal Bournemouth Hospital, Bournemouth

Ninewells Hospital and Medical School, Dundee

Kings College Hospital, Denmark Hill, London

Central Manchester and Manchester Children's University Hospitals NHS Trust, Manchester

Nottingham City Hospital, Nottingham

John Radcliffe Hospital and the Weatherall Institute of Molecular Medicine, Oxford